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Background: Complications increase the costs of care of surgical patients. We studied the Premier database to
determine the incidence and direct medical costs related to pulmonary complications and compared it to cardiac
complications in the same cohort.
Methods: We identified 45,969 discharges in patients undergoing major bowel procedures. Postoperative
pulmonary and cardiac complications were identified through the use of International Classification of Diseases,
Ninth Edition, Clinical Modification (ICD-9-CM) codes and through the use of daily resource use data. Pulmonary
complications included pneumonia, tracheobronchitis, pleural effusion, pulmonary failure, and mechanical
ventilation more than 48 h after surgery. Cardiac complications included ventricular fibrillation, acute myocardial
infarction, cardiogenic shock, cardiopulmonary arrest, transient ischemia, premature ventricular contraction, and
acute congestive heart failure.
Results: Postoperative pulmonary complications (PPC) or postoperative cardiac complications (PCC) were present
in 22% of cases; PPC alone was most common (19.0%), followed by PPC and PCC (1.8%) and PCC alone (1.2%).
The incremental cost of PPC is large ($25,498). In comparison, PCC alone only added $7,307 to the total cost.
Conclusions: The current study demonstrates that postoperative pulmonary complications represent a significant
source of morbidity and incremental cost after major small intestinal and colon surgery and have greater incidence
and costs than cardiac complications alone. Therefore, strategies to reduce the incidence of these complications
should be targeted as means of improving health and bending the cost curve in health care.
Keywords: Colectomy, Surgery, Postoperative, Pulmonary complications, Myocardial infarction, Cardiac arrest,
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During the past decade, there has been a marked de-
crease in surgical mortality [1]. This decrease appears to
be related in part to better treatment of complications in
some hospitals since perioperative complications remain
high and continue to be a significant source of both
decreased health and increased costs after surgery [2].* Correspondence: lee.fleisher@uphs.upenn.edu
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article, unless otherwise stated.Beginning in the 1970s, there was a concerted effort to
identify patients at increased risk of perioperative cardio-
vascular morbidity and mortality and to identify strategies
to reduce these complications. This has led to the develop-
ment and publication of formal Guidelines on Perioperative
Cardiovascular Evaluation and Management for Noncar-
diac Surgery and incorporation of specific therapies into
public performance measurement [3]. In contrast to car-
diovascular disease, the evaluation and management of
perioperative pulmonary complications has not had the
same degree of concerted effort to either identify those at
risk or implement additional risk reduction strategies.oMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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monary complications may in part be due to the lack of
recognition of their incidence and their economic burden
[4]. An additional issue is related to the definition of pul-
monary complications since there is wide variability in
manifestations of complications: from minor aspiration to
pneumonia to overt sepsis. Assessing the impact of pul-
monary complications is also difficult since a pulmonary
complication may lead to cardiovascular collapse with re-
sultant cardiac morbidity or mortality. Pulmonary compli-
cations may also be the final common pathway for major
morbidity or mortality in patients with other complica-
tions such as non-pulmonary infectious complications.
Given the lack of concerted attention in this important
area of health-care outcomes, we analyzed an enriched ad-
ministrative dataset to determine the incidence and direct
medical costs related to pulmonary complications in order
to provide more focused attention on the problem and
provide an impetus to identify cost-effective risk-reducing




We constructed the study cohort using the 2008 Premier
Hospital Discharge database. The Premier database (Premier,
Inc., Charlotte, NC, USA) includes information on all in-
patients and hospital-based outpatients treated in more
than 600 US hospitals. The database includes patient
demographic data and diagnosis codes; the date-stamped
log of all invoiced items, including procedures, medica-
tions, laboratory orders, diagnostic, and therapeutic
services; as well as devices used by individual patients.
The cohort of interest consisted of all discharges, age
18 years and older, in the Medicare Severity DRGs
329–331, major small and large bowel procedures.
For each case, we extracted the following: demographic
characteristics; principal diagnosis group (neoplasm,
colitis/diverticulitis, other); Charlson-Deyo co-morbidities;
postoperative pulmonary and cardiac complications; post-
operative length of stay (LOS); postoperative intensive
care unit (ICU) use; postoperative ICU LOS; total hospital
costs; and national projection weights.
Identification of postoperative complications
Postoperative pulmonary and cardiac complications were
identified through the use of International Classification
of Diseases, Ninth Edition, Clinical Modification (ICD-9-
CM) codes in any secondary coding space and through
the use of daily resource use data. Pulmonary complica-
tions included pneumonia (481, 482, 485, 486); tracheo-
bronchitis (494.1, 466, 464.1); pleural effusion (511.1,
511.8, 511.9); pulmonary failure (518.81, 518.84); and
mechanical ventilation more than 48 h after surgery(from daily resource use). Cardiac complications included
ventricular fibrillation (427.4); acute myocardial infarction
(410.X1); cardiogenic shock (785.51); cardiopulmonary ar-
rest (427.5); transient ischemia (411.1, 411.89); premature
ventricular contraction (PVC) (427.6); and acute congest-
ive heart failure (428.21, 428.31, 428.41).
Case-mix adjustment
We constructed a case-mix adjustment model to characterize
the impact of preoperative characteristics on the incidence
of postoperative complications and estimate the attribut-
able effects of PPC and PCC on resource use and out-
come. We constructed an analysis of variance model
using patients with no PPC and no PCC to predict total
cost as a function of age group; principal diagnosis group
(neoplasm—150–59, 183, 188, 195, 197, 209, 211, 214,
228, 230–35, 239; colitis/diverticulitis—555–569; and
other); and Charlson-Deyo co-morbidity. We chose cost
and not mortality risk as a severity measure because hos-
pital mortality is very low in those without postoperative
complications. The predicted cost equation was applied to
all cases, both those with and without postoperative com-
plications, and subjects were characterized by quintiles of
preoperative severity.
Resource use and outcome presentation
Overall mortality and resource use was presented dir-
ectly and also parsed into a base value, what was ex-
pected had there been no postoperative complications,
and an incremental effect, the difference between the
total and base values.
Statistical analysis
We compared continuous data using the Mann–Whitney
U test and categorical data by chi-squared or Fisher’s
exact test as appropriate. We organized patient data by
the presence of postoperative complications (PPC only,
PCC only, neither PPC nor PCC, and both PPC and PCC)
and by quintiles (Q) of preoperative severity. We gener-
ated national estimates using Premier-supplied weights.
We constructed the databases in FoxPro (Microsoft Corp,
Redmond, WA, USA) and conducted analyses in Data
Desk (Data Description, Ithaca, NY, USA).
Results
We identified 45,969 discharges with major small and
large bowel procedures. The average age was 62.9 years
and 45.1% were male. Descriptive characteristics are pro-
vided in Table 1. Colitis/diverticulitis was the most com-
mon principal diagnosis (43.7%), followed by neoplasm
(39.3%) and other (17.0%). More than a third of the cohort
(37.2%) had at least one Charlson-Deyo co-morbidity,
with diabetes being the most common (15.8%) followed
Table 1 Major small and large bowel procedure cohort characteristic, overall and by postoperative complication group
Variables All No PPC/PCC PPC alone PCC alone PPC and PCC
(n = 45,969) (n = 35,875) (n = 8,744) (n = 547) (n = 803)
Rate (%) 78.0 19.0 1.2 1.8
Hospital mortality (%) 3.6 0.7 11.9 12.6 36.1
Age (mean, years) 62.9 61.3 67.8 73.7 74.5
Age group (%)
18–34 5.4 6.2 3.2 0.9 0.6
35–54 23.8 26.5 15.6 6.2 5.7
55–64 21.3 22.3 18.5 14.3 10.8
65–74 22.2 21.7 23.7 23.9 25.7
75–84 19.7 17.6 26.0 35.8 37.0
85+ 7.5 5.8 12.9 18.8 20.2
Sex, male (%) 45.1 45.0 45.3 49.2 46.8
Race (%)
White 70.2 70.2 69.7 72.4 71.5
Black 10.4 10.0 12.0 11.2 12.0
Other 19.4 19.8 18.3 16.5 16.6
Charlson-Deyo co-morbidity (%)
Diabetes 15.8 14.6 19.9 22.7 24.7
Complicated diabetes 1.4 1.1 2.3 2.2 3.1
Chronic pulmonary disease 8.0 5.9 16.0 12.6 16.6
Chronic renal disease 6.4 4.4 12.9 14.1 21.2
Neoplasm 5.7 5.0 8.5 5.3 7.2
Metastatic neoplasm 13.1 12.6 14.6 14.6 14.1
Cerebrovascular disease 1.1 0.9 1.9 1.5 2.7
Dementia 0.3 0.2 0.6 1.1 0.6
Prior myocardial infarction 4.0 3.5 5.0 11.5 10.5
Para- and quadriplegia 0.4 0.3 0.9 0.9 1.4
Peripheral vascular disease 3.1 2.3 5.5 9.9 9.2
Chronic rheumatic disease 2.2 1.9 3.2 2.5 3.2
Mild liver disease 0.9 0.7 1.7 1.1 1.7
Severe liver disease 0.4 0.2 1.1 0.4 1.2
HIV 0.1 0.1 0.1 0.0 0.0
Any co-morbidity 37.2 34.1 47.2 53.2 55.8
Mean number 0.6 0.5 0.9 1.0 1.2
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Incidence and survival
Pulmonary or cardiac complications were present in 22%
of cases; PPC alone was most common (19.0%), followed
by PPC and PCC (1.8%) and PCC alone (1.2%). Those with
postoperative complications were older and had a greater
co-morbid burden than those that did not.
Those with PPC alone had 11.9% mortality and accounted
for nearly two thirds (63.6%) of hospital deaths (Figure 1).PCC alone cases had a similar mortality (12.6%) but
accounted for only 4.2% of deaths. Those with PPC and
PCC had the highest mortality (36.1%), though only 1.3%
of the cohort accounted for 17.7% of deaths.
Individual complications
Respiratory failure was the most common postoperative
complication, being present in one in eight patients with
21.8% mortality (Table 2). Other pulmonary complica-
tions ranged from 0.4% incidence (pneumothorax) to
6.1% (MV48). Overall, 20.8% of patients had at least one
Figure 1 Incidence, case distribution, and mortality for
postoperative complication groups.
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diac complications (2.9% incidence) were seven times
less frequent than pulmonary complications, but with
higher hospital mortality (26.6%). Acute myocardial in-
farction (AMI) was the most common PCC but occurred
in only 1.2% of patients.
Severity model
The average cost of those without PPC and PCC increased




Rate (%) Mortality (%)
Pulmonary
Pneumonia 2,249 (23.6) 4.9 14.4
Tracheobronchitis 434 (4.5) 0.9 6.2
Pleural effusion 1,584 (16.6) 3.4 13.7
Pulmonary collapse 3,499 (36.7) 7.6 6.2
Pneumothorax 189 (2.0) 2.0 24.9
Respiratory failure 5,686 (59.6) 12.4 21.8
MV48a 2,807 (29.4) 6.1 28.5
Any pulmonary 9,547 20.8 13.9
Cardiac
Ventricular fibrillation 63 (4.7) 0.1 61.9
AMI 570 (42.2) 1.2 26.7
Cardiogenic shock 64 (4.7) 0.1 57.8
Cardiopulmonary arrest 220 (16.3) 0.5 70.9
Transient ischemia 47 (3.5) 0.1 2.1
PVC 367 (27.2) 0.8 6.0
Acute CHF 175 (13.0) 0.4 14.9
Any cardiac 1,350 2.9 26.6
aMechanical ventilation more than 48 h after surgery.those under 35), principal diagnosis of colitis/diverticulitis
($2,487 more than neoplasm), and co-morbidity (diabetes
$1,091; peripheral vascular disease $1,493; cerebrovascular
disease $4,792; chronic pulmonary disease $1,044; rheum-
atic disease $1,544; complex diabetes $2,700; para- and
quadriplegia $3,422; chronic renal disease $6,046; and se-
vere liver disease $8,706). The rate of postoperative com-
plications increased greatly across the quintiles of severity
(Table 3), increasing from 11.0% in the first quintile to
41.7% in the fifth quintile. While PPC alone tripled from
10.5% in Q1 to 34.7% in Q5, the rate of PCC alone and
PPC and PCC increased by more than a factor of ten from
Q1 to Q5.
Hospital mortality and resource use by severity quintiles
The base mortality increased from 0.1% in Q1 to 2.2% in
Q5 for an overall value of 0.7% (Table 3). This is dwarfed
by the incremental mortality associated with PPC alone
(11.2% absolute), PCC alone (12.0%), and PPC and PCC
(35.5%) (Figure 2). While the base cost increased by
$5,909 between Q1 and Q5, the incremental cost of PPC is
large ($25,498) but increased only modestly from $22,199
in Q1 to $26,508 in Q5 (Figure 3). In comparison, PCC
alone only added $7,307 to the total cost. Overall, the in-
cremental cost of PPC is 153% of the mean base cost.
In contrast to mortality and cost, the base ICU use rate
increased greatly from 6.0% in Q1 to 23.3% in Q5. Those
with postoperative complications had much greater ICU
use. Postoperative ICU use for those with PPC rose from
48% in Q1 to 76% in Q5. This is much greater than PCC
alone and less than PPC and PCC, which in Q5 had an
ICU use rate of 83.2%. Base postoperative floor LOS
ranged from 5.9 days in Q1 to 7.6 days in Q5 with a mean
of 6.4 days. PPC alone added 3.5 days, greater than PCC
alone (1.3 days) and PPC and PCC (2.8 days). Base post-
operative ICU LOS was modest varying only from 0.2 days
in Q1 to 0.7 in Q5. The incremental postoperative ICU
LOS varied little by preoperative severity but could be
large: adding 1.1 ICU days for PCC, 4.5 ICU days for PPC,
and 7.1 ICU days for those with PPC and PCC.
National projections
Projecting to US national levels, there were 308,798
major small and large bowel procedure discharges in
2008, with 59,980 with PPC alone, 3,739 with PCC
alone, and 5,295 with PPC and PCC. The expected num-
ber of hospital deaths in the absence of PPC and PCC
was 2,370, only 21% of the observed 11,157 deaths. The
expected cost in the absence of postoperative complica-
tions was $5.25B, 75% of the observed $6.99B. Similarly,
in the absence of PPC and PCC, we would have ex-
pected 51.5% of the observed ICU use, 90% of postoper-
ative floor days, and 25% of ICU days to have been used.
In summary, PCC alone was associated with 3.8% of
Table 3 Association between preoperative severity, postoperative complications, and outcomes
Severity quintiles Q1 Q2 Q3 Q4 Q5 Total
(n = 8,403) (n = 9,976) (n = 8,846) (n = 9,174) (n = 9,574) (n = 45,969)
Complication rate (%)
PPC alone 10.5 14.5 13.9 20.3 34.7 19.0
PCC alone 0.2 1.3 0.8 1.3 2.2 1.2
PPC and PCC 0.3 1.1 1.0 1.4 4.7 1.7
Any complication 11.0 16.9 15.7 23.0 41.7 21.9
Base mortality (%) 0.1 0.4 0.3 0.7 2.2 0.7
Incremental mortality (%)
PPC alone 5.2 7.9 8.3 8.5 15.8 11.2
PCC alone 3.1 7.5 6.4 8.7 15.6 12.0
PPC and PCC 13.5 35.0 33.8 32.9 36.3 35.5
Base cost ($) 14,875 15,438 16,017 17,462 20,784 16,672
Incremental cost ($)
PPC alone 22,199 24,199 24,658 26,817 26,508 25,498
PCC alone 5,524 5,528 9,070 4,057 9,765 7,307
PPC and PCC 45,308 48,950 38,096 30,884 31,394 34,872
Base ICU use (%) 6.0 9.0 8.2 11.8 23.3 11.0
Incremental ICU use (%)
PPC alone 42.0 45.7 50.2 54.0 52.7 54.0
PCC alone 9.8 24.9 33.1 20.4 25.2 28.5
PPC and PCC 71.2 67.1 75.3 68.3 59.9 70.6
Base post-op ICU LOS (days) 0.2 0.2 0.2 0.3 0.7 0.3
Incremental post-op ICU LOS (days)
PPC alone 3.0 4.0 3.7 4.6 5.0 4.5
PCC alone 0.4 0.7 1.0 0.6 1.4 1.1
PPC and PCC 7.5 8.0 7.5 6.7 6.5 7.1
Base post-op floor LOS (days) 5.9 6.3 6.4 6.6 7.6 6.5
Incremental post-op floor LOS (days)
PPC alone 3.0 4.0 3.7 4.6 5.0 4.5
PCC alone 0.4 0.7 1.0 0.6 1.4 1.1
PPC and PCC 7.5 8.0 7.5 6.7 6.5 7.1
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alone with 58.5% of all deaths.
Discussion
The current study demonstrates that postoperative pul-
monary complications represent a significant source of
morbidity and incremental cost after major small intestinal
and colon surgery and have greater incidence and costs
than cardiac complications alone. Although PPC alone was
associated with a high incidence of mortality (11.9%), the
combination of PPC and PCC together was associated with
the greatest risk. The incidence increased with increasing
age until 85 years of age, with over 20% of all patients ex-
periencing some form of pulmonary complication.The high incidence of pulmonary complications is
consistent with studies utilizing the American College
of Surgeons National Surgical Quality Improvement
Program (ACS NSQIP), although the actual rate is higher
than that in their selected population of hospitals [5]. This
may reflect differences in the definition of PPC we used,
which included a larger group of diagnoses, or it may
reflect differences between hospitals enrolled in a quality
improvement program compared to a more random
sample. Importantly, we observed a 4.9% incidence of
postoperative pneumonia and 6.1% incidence of mech-
anic ventilation greater than 24 h, which is consistent with
other studies. For example, Kennedy and colleagues re-
ported a 25.4% incidence of complications for surgery for
Figure 2 Base and incremental mortalities for postoperative
complication groups by preoperative severity groups.
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second most common complication after superficial site
infection [6]. In contrast, Arozullah and colleagues ob-
served a 1.5% incidence of postoperative pneumonia in a
mixed group of major noncardiac surgery at 100 Veterans
Administration Medical Centers [7]. The lower incidence
of pneumonia in this population may reflect the type of
surgery compared to a cohort of major abdominal surgery
in our study.
We observed a high mortality associated with PPC, par-
ticularly those with concomitant PCC. Arozullah and col-
leagues observed a 21% incidence of 30-day mortality in
those patients with pneumonia compared to our 14.4%
incidence of in-hospital mortality. Jencks and colleagues
demonstrated that patients with postoperative pneumonia
have a high incidence of readmission, and therefore, our
in-hospital mortality rate may not reflect the true 30-day
incident [8]. Additionally, we observed a more contem-
porary cohort of non-Veterans Administration MedicalFigure 3 Base and incremental costs for postoperative complication
groups by preoperative severity groups.Centers, and they may actually have a better failure-to-
rescue rate.
We observed that postoperative cardiac complications
continue to occur at low rates (2.9% overall incidence
with 1.2% incidence of AMI) but are associated with a
high mortality rate. This is consistent with other studies.
For example, Dimick and colleagues at the University of
Michigan found the incidence of 30-day cardiovascular
complications to be 1% overall in a cohort of general and
vascular surgery patients [9]. A 26.6% in-hospital mortality
is consistent with most contemporary studies and suggests
that while decreasing in frequency, cardiac complications
still carry a significant mortality. When evaluating the mor-
tality rate for either complication, it is important to isolate
solitary complications from those that are combined.
PPC was associated with a significant increased length
of stay and overall costs. Dimick and colleagues demon-
strated a $62,704 average increment in costs in those pa-
tients with PPC in a mixed cohort of patients [9]. Khan
and colleagues reported an increased hospital length of
stay of 89% and increased costs by 55%, which is more
consistent with our findings [10]. Thompson and col-
leagues studied abdominal surgical patients and demon-
strated an increased hospital length of stay of 11 days and
charges of $31,000 associated with PPC [11]. Short and
colleagues utilized Medicare claims for the years 2005
through 2009 in six cancer resections and assessed the
rate of complications using the Agency for Healthcare
Research and Quality Patient Safety Indicators (PSI) [12].
They found that the rate of postoperative respiratory fail-
ure was 2.58% and increased costs by >50% for all cancer
resections. Vaughan-Sarrazin and colleagues looked at
cost of complications in general surgery patients in the
Veterans Administration NSQIP as a means of building
a business case for improving surgical quality [13]. The
average cost for patients with no complication was
$22,000, while the total costs for patients with a pulmon-
ary embolism was $62,726 and increased to more than
$115,000 for patients with failure to wean from the venti-
lator within 48 h of operation.
The significant medical and economic burden of post-
operative pulmonary or cardiopulmonary complications
clearly suggest that increased attention should be di-
rected at reducing this complication. We included an
analysis of cardiac complications in order to assess the
importance of pulmonary complications in perspective.
The past decade has seen numerous studies published
which have evaluated interventions to reduce cardiac
complications of noncardiac surgery [3]. Similar studies
are lacking in the area of reducing the incidence and
burden of pulmonary complications. Shander and col-
leagues have recently reported on a patient safety sum-
mit dedicated to risk-reducing and preventive strategies
[4]. They have emphasized the paucity of data regarding
Fleisher and Linde-Zwirble Perioperative Medicine 2014, 3:7 Page 7 of 7
http://www.perioperativemedicinejournal.com/content/3/1/7such strategies as well as discussed potential technolo-
gies and strategies to reduce the incidence of ventilator-
associated pneumonia.
Our study has several limitations related to the use of
administrative claims to assess burden and costs of dis-
ease. By using the Premier database, we have the distinct
advantage of daily resource utilization and an enriched
set of diagnostic codes. However, we still have the inherent
limitation of any such dataset with regard to the accuracy
of the codes and inclusions of all potentially relevant vari-
ables. For example, we did not analyze smoking status
given the inaccuracy of this variable in discharge data.
With respect to outcome measures, hospitals may have
different definitions of the individual outcomes and sur-
veillance for such outcomes. We also made some assump-
tions regarding the sequence of cardiac versus respiratory
complications that could influence our findings.
Conclusions
We have demonstrated that postoperative pulmonary com-
plications, either in isolation or in tandem with postopera-
tive cardiac complications, occur at a high incidence after
intestinal surgery and are associated with significant mor-
tality and costs. Therefore, strategies to reduce the inci-
dence of these complications should be targeted as means
of improving health and bending the cost curve in health
care.
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